New Delhi/ Chandigarh: It may take a while before stem cell therapy becomes the first line of treatment in diabetes management but end stage diabetic patients becoming resistant to medication are getting new lease of life, thanks to autologous stem cell intervention. Evidences are mounting fast in support of stem cell protocol in the management of diabetes.
Sample this: for 74 year old diabetic Chandigarh woman Mrs Kanika (name changed), it seemed end of the road. The type 2 diabetic had reached plateau in medication. Her blood sugar levels would be quite high despite medication. But thanks to stem cell therapy, hope has floated high for her instead of blood sugar. Hers has been a veritable miracle achieved with her own stem (autologous) cells. Her blood glucose is today well under control and she enjoys a much better quality of life.
The two day 2nd International Regenerative Medicine Conclave 2018 in Chandigarh, starting on May 12, will be marked by showcase of many such robust evidences of cell based diabetes management by a number of cell therapy experts from all over India.
The cell based intervention on Kanika was done at GM Nursing Home in Chandigarh, under able guidance of CEO of StemGenn Therapeutics, Dr Prabhu Mishra, an ace stem cell scientist and his team of clinicians, Dr Shaloo Gupta and Dr Pawan Gupta. StemGenn Therapeutics and GM Nursing Home are in a joint venture for stem cell therapy.
Talking to Medicare News, Dr Prabhu Mishra, founder president, Anti Ageing Foundation and organizing secretary of the conclave, said, ‘Stem Cell therapy is an extremely effective, safe and reasonably-priced procedure which could extend the frontiers of diabetic management and possibly even provide a cure someday with more trial studies. Patients report excellent control of blood sugar level after being treated with stem cells derived from their bone marrow. Cell therapy is all set to be the future of diabetes management.’
Dr Mishra, whose StemGenn Therapeutics specialises in retrieval of best quality stem cells, further said, ‘People need to be made aware of the immense potential of this treatment for diabetic management. Kanika is only one of many cases wherein stem cell therapy has given excellent result. An 83- year-old gentleman with type 2 diabetes was administered the therapy bringing down his HbA1c level from high 6.6 to a normal 5.8, while Mrs Kanika came down from 6.8 to 6. Both the patients were advised to maintain their regular routine involving exercise, medication course, and diet immediately before and for 90 days after the treatment. Both of them received the treatment once and their glucose levels were monitored daily at home and once a month at a NABL accredited laboratory. In both the patients, the fasting, postprandial (i.e. after meals) and HbA1c (i.e. average for 3 months) sugar levels decreased significantly after cell therapy treatment.’
Giving details of the procedure, Dr Mishra says: ‘after checking the patient’s blood sugar fasting, blood sugar (PP) and glycated hemoglobin (HbA1c) (H.P.L.C), about 60 mL of bone marrow is aspirated from the patient’s posterior iliac crest under general anesthesia. This bone marrow aspirate is then processed using an advanced and fully automated bone marrow processing system, namely, The Arthrex Angel SystemTM to harvest the bone marrow concentrate. In the end, the bone marrow concentrate is administered intravenously to the patient. The patient is kept under observation for 4-5 hours and then discharged after that.’
Vouching for the efficacy of cell therapy, Dr Mishra says that stem cells therapy could be the panacea, for not just diabetes, but for all kinds of metabolic diseases in the coming years.
The occasion will facilitate discussions on Aesthetic Medicine, Regenerative Medicine, Cell therapy, Anti Ageing and novel technologies in healthcare. Key Focus would be Cosmetic Gynecology, infertility, regenerative orthopaedics, Cardio Vascular and metabolic disorder. The conclave is being organized by Women Wellness Forum, Anti Ageing Foundation (Society of Regenerative, aesthetic and functional medicine) and ISCSG (Indian Stem Cell study group).
As for diabetic management, Stem cells have a unique ability to replicate into new cell types. Type 2 diabetes is a situation where the insulin produced by the body, is not able to digest or metabolize the blood glucose. In stem cell treatment, autologous stem cells procured from various sources from the patient’s body including bone marrow, fat adipose tissue, etc. are reintroduced into the patient’s body. These cells multiply speedily, repairing and replacing the damaged cells. They stimulate the formation of new islets of Langerhans in the pancreas that boost the production of insulin and bring down the blood sugar level. This has proved a marvel in both type 1 and type 2 diabetes. There is a significant reduction in the insulin dosage with remarkable improvement in the general health of the diabetic patient.
